Literature DB >> 22426463

Degradation of human RAP80 is cell cycle regulated by Cdc20 and Cdh1 ubiquitin ligases.

Hyun Jung Cho1, Eun Hee Lee, Seung Hun Han, Hee Jin Chung, Ji Hoon Jeong, Junhye Kwon, Hongtae Kim.   

Abstract

Receptor-associated protein 80 (RAP80) is a component of the BRCA1-A complex that recruits BRCA1 to DNA damage sites in the DNA damage-induced ubiquitin signaling pathway. RAP80-depleted cells showed defective G(2)-M phase checkpoint control. In this study, we show that RAP80 protein levels fluctuate during the cell cycle. Its expression level peaked in the G(2) phase and declined during mitosis and progression into the G(1) phase. Also, RAP80 is polyubiquitinated and degraded by the anaphase-promoting complex (APC/C)(Cdc20) or (APC/C)(Cdh1). Consistent with this, knockdown of Cdc20 or Cdh1 expression by transfecting with small interfering RNAs blocked RAP80 degradation during mitosis or the G(1) phase, respectively. A conserved destruction box (D box) in RAP80 affected its stability and ubiquitination, which was dependent on APC/cyclosome(Cdc20) (C(Cdc20)) or APC/cyclosome(Cdh1) (C(Cdh1)). In addition, overexpression of RAP80 destruction box1 deletion mutant attenuated mitotic progression. Thus, APC/C(Cdc20) or APC/C(Cdh1) complexes regulate RAP80 stability during mitosis to the G(1) phase, and these events are critical for a novel function of RAP80 in mitotic progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426463     DOI: 10.1158/1541-7786.MCR-11-0481

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  12 in total

Review 1.  Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Authors:  Jinfang Zhang; Lixin Wan; Xiangpeng Dai; Yi Sun; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 2.  Regulation and roles of Cdc7 kinase under replication stress.

Authors:  Masayuki Yamada; Hisao Masai; Jiri Bartek
Journal:  Cell Cycle       Date:  2014-05-19       Impact factor: 4.534

Review 3.  Targeting Cdc20 as a novel cancer therapeutic strategy.

Authors:  Lixia Wang; Jinfang Zhang; Lixin Wan; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Pharmacol Ther       Date:  2015-04-04       Impact factor: 12.310

4.  Cdk1 protein-mediated phosphorylation of receptor-associated protein 80 (RAP80) serine 677 modulates DNA damage-induced G2/M checkpoint and cell survival.

Authors:  Hyun Jung Cho; Yun Jung Oh; Seung Hun Han; Hee Jin Chung; Chang Hee Kim; Nam Soo Lee; Won-Ju Kim; Je-Min Choi; Hongtae Kim
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

Review 5.  Insights into APC/C: from cellular function to diseases and therapeutics.

Authors:  Zhuan Zhou; Mingjing He; Anil A Shah; Yong Wan
Journal:  Cell Div       Date:  2016-07-13       Impact factor: 5.130

6.  ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress.

Authors:  Masayuki Yamada; Kenji Watanabe; Martin Mistrik; Eva Vesela; Iva Protivankova; Niels Mailand; MyungHee Lee; Hisao Masai; Jiri Lukas; Jiri Bartek
Journal:  Genes Dev       Date:  2013-11-15       Impact factor: 11.361

Review 7.  Controlling the response to DNA damage by the APC/C-Cdh1.

Authors:  H Rudolf de Boer; S Guerrero Llobet; Marcel A T M van Vugt
Journal:  Cell Mol Life Sci       Date:  2015-12-09       Impact factor: 9.261

8.  Interactome Analysis Reveals that Heterochromatin Protein 1γ (HP1γ) Is Associated with the DNA Damage Response Pathway.

Authors:  Hongtae Kim; Jae Duk Choi; Byung-Gyu Kim; Ho Chul Kang; Jong-Soo Lee
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

Review 9.  Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis.

Authors:  Soung-Hun Roh; Moses Kasembeli; Deenadayalan Bakthavatsalam; Wah Chiu; David J Tweardy
Journal:  Int J Mol Sci       Date:  2015-11-06       Impact factor: 5.923

10.  Erratum to: Controlling the response to DNA damage by the APC/C-Cdh1.

Authors:  H Rudolf de Boer; Sergi Guerrero Llobet; Marcel A T M van Vugt
Journal:  Cell Mol Life Sci       Date:  2016-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.